12th edition of the conference in Hyderabad will have seven focus areas
12th edition of the conference in Hyderabad will have seven focus areas
Industry hails the move
Mycophenolate Mofetil is an immunosuppressant to help prevent organ rejection in transplants and Rizatriptan is used for the treatment of…
RPG Life Sciences has appointed CT Renganathan as its Managing Director and an Additional Director for a term of three…
The completion of this transaction will focus Novartis on its three leading businesses of global scale: innovative pharmaceuticals, eye care,…
Partners with CAIRN, UNICEF and IIT to improve child and maternal healthcare in rural areas
With COMSOL Server, applications can now be distributed throughout an organisation, providing design teams, production departments, and others with access…
The Ministry of Commerce & Industry has invited comments form all stakeholders on the first draft of the National IPR…
Lupin has received tentative approval for its darunavir ethanolate tablets 75 mg, 150 mg, 300 mg, 400 mg, 600 mg…
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven
The large portion of patents going to foreign companies clearly indicates that the Indian patent regime is non-discriminatory and strong
Would commence marketing the product shortly
First interleukin-17A inhibitor to get Japanese nod for either indication
Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a…
The Department of Industrial Policy and Promotion (DIPP) has published the first draft of the national IPR policy yesterday. Dated…
Industry hails move; asks for more changes to “pro imports” policies
It involves acquisition of GSK’s portfolio of oncology products by Novartis for $16 billion
Clinical research in India has gone through Dickensian times in the past two years. Alishan Naqvee, Partner and Abhijeet Das,…